These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8285615)
1. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin. Lang R; Shasha B; Rubinstein E Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615 [TBL] [Abstract][Full Text] [Related]
2. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864 [TBL] [Abstract][Full Text] [Related]
3. Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin. Shasha B; Lang R; Rubinstein E Antimicrob Agents Chemother; 1992 May; 36(5):973-6. PubMed ID: 1510422 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis. Shasha B; Lang R; Rubinstein E J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118 [TBL] [Abstract][Full Text] [Related]
5. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939 [TBL] [Abstract][Full Text] [Related]
6. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878 [TBL] [Abstract][Full Text] [Related]
7. Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections. Domingo S; Gamazo C J Chemother; 1996 Feb; 8(1):55-8. PubMed ID: 8835110 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice. Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379 [TBL] [Abstract][Full Text] [Related]
9. Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey. Gültekin E; Uyanık MH; Albayrak A; Kılıç S Eur J Med Res; 2021 Jun; 26(1):57. PubMed ID: 34134763 [TBL] [Abstract][Full Text] [Related]
10. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716 [TBL] [Abstract][Full Text] [Related]
11. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. Converse PJ; Tyagi S; Xing Y; Li SY; Kishi Y; Adamson J; Nuermberger EL; Grosset JH PLoS Negl Trop Dis; 2015; 9(6):e0003823. PubMed ID: 26042792 [TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp. Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865 [No Abstract] [Full Text] [Related]
14. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection. Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis. Lang R; Shasha B; Ifrach N; Tinman S; Rubinstein E Chemotherapy; 1994; 40(4):252-5. PubMed ID: 8082413 [TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs. Mateu-de-Antonio EM; Martín M Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024 [TBL] [Abstract][Full Text] [Related]
18. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats. Yumuk Z; Dundar V J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439 [TBL] [Abstract][Full Text] [Related]
19. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice. Domingo S; Díaz R; Gamazo C FEMS Immunol Med Microbiol; 1995 Oct; 12(2):91-5. PubMed ID: 8589668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]